| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6261546 | BAUSCH AND LOMB | Methods and compositions for stabilizing acetylcholine compositions |
Apr, 2019
(5 years ago) | |
Miochol-E is owned by Bausch And Lomb.
Miochol-E contains Acetylcholine Chloride.
Miochol-E has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Miochol-E are:
- US6261546
Miochol-E was authorised for market use on 22 September, 1993.
Miochol-E is available in for solution;ophthalmic dosage forms.
Miochol-E can be used as pharm product container 1st chamber is disposed aqueous diluent sol 2nd chamber pharm active agent comprising acetylcholine,buffer in 1st cham is sufficient to buffer ph of mixed sol resulting mixture of aqueous diluent sol & pharm active...
The generics of Miochol-E are possible to be released after 29 April, 2019.
Drugs and Companies using ACETYLCHOLINE CHLORIDE ingredient
Market Authorisation Date: 22 September, 1993
Treatment: Pharm product container 1st chamber is disposed aqueous diluent sol 2nd chamber pharm active agent comprising acetylcholine,buffer in 1st cham is sufficient to buffer ph of mixed sol resulting mixture...
Dosage: FOR SOLUTION;OPHTHALMIC
MIOCHOL-E family patents
